Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis
Trial details
- Registry ID
- NCT06890923
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple SclerosisNCT06890923 | TLSA | Phase 2 | Recruiting | 2026-04-30Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |